| Anne Marie Thomas, MD | |
|
931 Highland Blvd Ste 3210, Bozeman, MT 59715-6912 | |
| (406) 414-2410 | |
| Not Available |
| Full Name | Anne Marie Thomas |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 22 Years |
| Location | 931 Highland Blvd Ste 3210, Bozeman, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346276888 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bozeman Health Deaconess Hospital | Bozeman, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bozeman Health Deaconess Hospital | 4688984164 | 233 |
News Archive
A team of researchers recently investigated the genetic determinants of COVID-19 risk and severity in humans.
Advanced Cell Technology, Inc. announced today that it has strengthened its balance sheet through the elimination of approximately $3 million in debt over the past several weeks. The conversion of senior and subordinated debentures to equity has reduced the Company's outstanding convertible debentures to approximately $890,000. Since September 2009, Advanced Cell has eliminated approximately $33 million in indebtedness.
Antihypertensive therapy reduces the risk of cardiovascular (CV) events, strokes and mortality in hypertensive older adults, according to research presented at ESC Congress 2014 today by Dr Maciej Ostrowski from Poland.
Anavex Life Sciences Corp. will present the most recent data showing the therapeutic potential of ANAVEX compounds in animal models of Alzheimer's disease at a special symposium of the 34th annual meeting of the Japan Neuroscience Society. The symposium is being held in Yokohama, Japan from September 15-17, 2011.
› Verified 5 days ago
| Entity Name | Community Health Partners Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487741005 PECOS PAC ID: 5799681482 Enrollment ID: O20031211001095 |
News Archive
A team of researchers recently investigated the genetic determinants of COVID-19 risk and severity in humans.
Advanced Cell Technology, Inc. announced today that it has strengthened its balance sheet through the elimination of approximately $3 million in debt over the past several weeks. The conversion of senior and subordinated debentures to equity has reduced the Company's outstanding convertible debentures to approximately $890,000. Since September 2009, Advanced Cell has eliminated approximately $33 million in indebtedness.
Antihypertensive therapy reduces the risk of cardiovascular (CV) events, strokes and mortality in hypertensive older adults, according to research presented at ESC Congress 2014 today by Dr Maciej Ostrowski from Poland.
Anavex Life Sciences Corp. will present the most recent data showing the therapeutic potential of ANAVEX compounds in animal models of Alzheimer's disease at a special symposium of the 34th annual meeting of the Japan Neuroscience Society. The symposium is being held in Yokohama, Japan from September 15-17, 2011.
› Verified 5 days ago
| Entity Name | Bozeman Health Deaconess Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619347390 PECOS PAC ID: 4688984164 Enrollment ID: O20151112002559 |
News Archive
A team of researchers recently investigated the genetic determinants of COVID-19 risk and severity in humans.
Advanced Cell Technology, Inc. announced today that it has strengthened its balance sheet through the elimination of approximately $3 million in debt over the past several weeks. The conversion of senior and subordinated debentures to equity has reduced the Company's outstanding convertible debentures to approximately $890,000. Since September 2009, Advanced Cell has eliminated approximately $33 million in indebtedness.
Antihypertensive therapy reduces the risk of cardiovascular (CV) events, strokes and mortality in hypertensive older adults, according to research presented at ESC Congress 2014 today by Dr Maciej Ostrowski from Poland.
Anavex Life Sciences Corp. will present the most recent data showing the therapeutic potential of ANAVEX compounds in animal models of Alzheimer's disease at a special symposium of the 34th annual meeting of the Japan Neuroscience Society. The symposium is being held in Yokohama, Japan from September 15-17, 2011.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anne Marie Thomas, MD 915 Highland Blvd, Bozeman, MT 59715-6902 Ph: (406) 414-5000 | Anne Marie Thomas, MD 931 Highland Blvd Ste 3210, Bozeman, MT 59715-6912 Ph: (406) 414-2410 |
News Archive
A team of researchers recently investigated the genetic determinants of COVID-19 risk and severity in humans.
Advanced Cell Technology, Inc. announced today that it has strengthened its balance sheet through the elimination of approximately $3 million in debt over the past several weeks. The conversion of senior and subordinated debentures to equity has reduced the Company's outstanding convertible debentures to approximately $890,000. Since September 2009, Advanced Cell has eliminated approximately $33 million in indebtedness.
Antihypertensive therapy reduces the risk of cardiovascular (CV) events, strokes and mortality in hypertensive older adults, according to research presented at ESC Congress 2014 today by Dr Maciej Ostrowski from Poland.
Anavex Life Sciences Corp. will present the most recent data showing the therapeutic potential of ANAVEX compounds in animal models of Alzheimer's disease at a special symposium of the 34th annual meeting of the Japan Neuroscience Society. The symposium is being held in Yokohama, Japan from September 15-17, 2011.
› Verified 5 days ago
Robert Sise, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 5 W Mendenhall St Ste 202, Bozeman, MT 59715 Phone: 406-219-7233 | |
Dr. Thomas James Heriza, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1871 S 22nd Ave Ste 3, Bozeman, MT 59718 Phone: 406-585-3584 Fax: 406-534-0411 | |
Dr. Joshua Aaron Knappenberger, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 931 Highland Blvd Ste 3260, Bozeman, MT 59715 Phone: 406-522-2410 | |
Dr. Alexis Paige Anderson, D.O. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 5 W Mendenhall St Ste 202, Bozeman, MT 59715 Phone: 406-589-2402 | |
Michelle Dechant Barton, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 937 Highland Blvd Ste 5410, Bozeman, MT 59715 Phone: 406-414-2400 Fax: 406-414-3610 | |
Dr. Patricia Fowlie, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 321 E Main St Ste 304, Bozeman, MT 59715 Phone: 406-585-7111 | |
Dr. David Keith Lorance Jr., M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 931 Highland Blvd Ste 3210, Bozeman, MT 59715 Phone: 406-414-2410 |